Dusigitumab — properties from Wikipedia — wikidata.cheminfo.org

DusigitumabDusigitumab is a human monoclonal antibody designed for the treatment of cancer. It binds to IGF2. It was developed by MedImmune, which was acquired by AstraZeneca, using Xenomouse technology licensed from Abgenix. Read from the Drugbox of the Wikipedia article Dusigitumab, revision 1190942583.

Property

Value

Formula

C6372H9824N1700O2016S54, 144232.11 g/mol

The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.

Search — compounds by structure and property

About — sources, licence, and how to cite

Status — the daily update

API documentation

Our other tools

learn.cheminfo.org

inchi.cheminfo.org

vcl.cheminfo.org

smiles.cheminfo.org

iupac-name.cheminfo.org

openbabel.cheminfo.org

www.chemcalc.org

dbe.cheminfo.org

metabo.nmrium.com

derepflow.cheminfo.org

surge.cheminfo.org

tex.cheminfo.org

lcao.cheminfo.org

regexp.cheminfo.org

pdb.cheminfo.org

elucidation.cheminfo.org

equilibrium.cheminfo.org

polycarp.cheminfo.org

3d.cheminfo.org

periodic-table.cheminfo.org

database.cheminfo.org

symmetry.cheminfo.org

osiris.cheminfo.org

atoms.cheminfo.org

moles.cheminfo.org

inorganic.cheminfo.org

powerpoint.cheminfo.org